Bryan T Hennessy Selected Research

Bryan T Hennessy Research Topics

Disease

65	Neoplasms (Cancer) 02/2023 - 12/2003
51	Breast Neoplasms (Breast Cancer) 03/2024 - 08/2005
20	Ovarian Neoplasms (Ovarian Cancer) 11/2023 - 01/2009
8	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 03/2017
7	Neoplasm Metastasis (Metastasis) 10/2020 - 12/2005
7	Carcinogenesis 01/2020 - 12/2003
6	Ovarian Epithelial Carcinoma 07/2012 - 01/2009
5	Endometrial Neoplasms (Endometrial Cancer) 01/2018 - 07/2011
4	Disease Progression 03/2021 - 04/2011
3	Lung Neoplasms (Lung Cancer) 02/2024 - 01/2018
3	Pathologic Complete Response 11/2023 - 03/2006
3	Melanoma (Melanoma, Malignant) 01/2020 - 06/2015
3	Carcinoma (Carcinomatosis) 02/2014 - 04/2009
2	Triple Negative Breast Neoplasms 11/2023 - 08/2022
2	Adenocarcinoma 06/2023 - 02/2019
2	Noninfiltrating Intraductal Carcinoma (DCIS) 03/2022 - 12/2007
2	COVID-19 11/2021 - 01/2021
2	Rectal Neoplasms (Rectal Cancer) 07/2020 - 08/2014
2	Lymphatic Metastasis 04/2009 - 03/2006
2	Inflammatory Breast Neoplasms 03/2006 - 08/2005
1	Genomic Instability 11/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2023
1	Neutropenia 02/2023
1	Febrile Neutropenia 02/2023
1	Mucositis 02/2023
1	Infections 02/2023
1	Breast Ductal Carcinoma 03/2022
1	Ischemic Stroke 11/2021

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2008
17	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2009
15	Estrogen ReceptorsIBA 11/2023 - 12/2007
12	Phosphotransferases (Kinase)IBA 08/2022 - 04/2009
11	Trastuzumab (Herceptin)FDA Link 01/2024 - 10/2007
11	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2017 - 08/2008
8	PlatinumIBA 11/2023 - 04/2011
7	Hormones (Hormone)IBA 10/2012 - 11/2005
6	Lapatinib (GW572016)FDA Link 10/2023 - 07/2017
6	DNA (Deoxyribonucleic Acid)IBA 06/2023 - 05/2009
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2023 - 08/2014
4	human ERBB2 proteinIBA 01/2023 - 07/2017
4	AntibodiesIBA 11/2020 - 12/2010
4	Bevacizumab (Avastin)FDA Link 01/2020 - 10/2009
4	taxaneIBA 06/2014 - 07/2011
4	Phenobarbital (Luminal)FDA Link 10/2013 - 05/2009
3	Paclitaxel (Taxol)FDA LinkGeneric 02/2023 - 03/2006
3	Cisplatin (Platino)FDA LinkGeneric 08/2022 - 11/2012
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 06/2013
3	copanlisibIBA 03/2021 - 10/2017
3	AfatinibIBA 01/2021 - 01/2018
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 05/2009
3	ErbB Receptors (EGF Receptor)IBA 11/2020 - 01/2010
3	Carboplatin (JM8)FDA LinkGeneric 07/2017 - 10/2009
3	Estrogens (Estrogen)FDA Link 07/2014 - 04/2009
3	Small Interfering RNA (siRNA)IBA 02/2014 - 05/2009
3	Messenger RNA (mRNA)IBA 06/2013 - 05/2009
3	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 05/2012 - 04/2009
3	Tamoxifen FDA LinkGeneric 01/2012 - 08/2008
3	AnthracyclinesIBA 12/2011 - 03/2006
3	Mechanistic Target of Rapamycin Complex 1IBA 07/2011 - 06/2010
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2010 - 04/2009
2	pertuzumabIBA 01/2024 - 01/2021
2	trastuzumab deruxtecanIBA 01/2024 - 12/2023
2	Immunoconjugates (Immunoconjugate)IBA 01/2024 - 12/2023
2	MicroRNAs (MicroRNA)IBA 11/2021 - 10/2014
2	src-Family KinasesIBA 10/2020 - 04/2017
2	RNA (Ribonucleic Acid)IBA 07/2020 - 01/2016
2	Capecitabine (Xeloda)FDA Link 01/2020 - 12/2011
2	Dasatinib (BMS 354825)FDA Link 01/2020 - 04/2017
2	NucleotidesIBA 01/2020 - 06/2015
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2017 - 05/2009
2	Docetaxel (Taxotere)FDA Link 07/2017 - 07/2012
2	perifosineIBA 07/2012 - 12/2007
2	TensinsIBA 05/2012 - 05/2009
2	Estrogen Receptor Modulators (Antiestrogen)IBA 07/2011 - 05/2009
2	Fulvestrant (Faslodex)FDA Link 07/2011 - 05/2009
2	Chemokine CXCL12IBA 02/2011 - 01/2010
2	TenascinIBA 02/2011 - 01/2010
2	Conditioned Culture MediaIBA 02/2011 - 01/2010
1	Histone MethyltransferasesIBA 03/2024
1	mirdametinibIBA 12/2023
1	gedatolisibIBA 12/2023
1	palbociclibIBA 12/2023
1	Protein Tyrosine PhosphatasesIBA 06/2023
1	pegfilgrastim (Neulasta)FDA Link 02/2023
1	Junctional Adhesion Molecule AIBA 03/2022
1	Epidermal Growth Factor (EGF)IBA 03/2022
1	LCL161IBA 01/2022
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 11/2021
1	AMP-Activated Protein KinasesIBA 11/2021
1	Glutamic Acid (Glutamate)FDA Link 11/2021
1	4-azidobenzylcarazolol (pABC)IBA 08/2021
1	Vincristine (Oncovin)FDA LinkGeneric 02/2021
1	Procarbazine (Matulane)FDA Link 02/2021

Therapy/Procedure

38	Therapeutics 01/2024 - 12/2003
25	Drug Therapy (Chemotherapy) 01/2024 - 06/2004
6	Neoadjuvant Therapy 09/2023 - 08/2005
1	Radiotherapy 02/2024
1	Withholding Treatment 02/2023
1	Treatment Delay 02/2023